Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Michigan.
Press releases published on September 4, 2025
Ambs Call Center Earns HIPAA Recertification, Cementing Patient Care Legacy
Renewed certification highlights Ambs Call Center’s commitment to safeguarding patient data and supporting healthcare providers nationwide. MI, UNITED STATES, September 4, 2025 /EINPresswire.com/ -- Ambs Call Center, the 93-year-old medical answering …
Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology
SALT LAKE CITY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced The Lancet Oncology published a study highlighting the performance of Myriad’s …
Four Renowned Physicians Honored with Endowed Chairs at Providence Saint John’s Health Center
SANTA MONICA, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Providence Saint John’s Health Center honored four distinguished physicians during its second annual endowed chair investiture ceremony, held Sept. 3 at the Brentwood Country Club in Brentwood, Calif …
Biorad Medisys announces its entry into the US market with the launch of its new subsidiary Medtimo Inc.
PUNE, India, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Biorad Medisys, an Indian medical device manufacturer with a global footprint, has announced its entry into the US market with the launch of its subsidiary Medtimo Inc. The move comes post Biorad Medisys’ …
MD Logic Health and Dr. Roxanne Carfora Launch Advanced Cholesterol Support: A Doctor-Created Formula for Heart and Metabolic Wellness
Miami, Florida , Sept. 04, 2025 (GLOBE NEWSWIRE) -- MD Logic Health®, a trusted leader in science-backed wellness solutions, has partnered with Dr. Roxanne Carfora, D.O., P.C., a Board Certified Anti-Aging and Regenerative Medicine Specialist, to launch …
Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout
Results from long-term follow up of patients treated with atrioventricular interval modulation (“AVIM”) therapy show blood pressure-lowering effects are sustained for years after activation, reversible with no observed rebound hypertension upon …
ADARx Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
SAN DIEGO, Sept. 04, 2025 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA therapeutics, will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on …
Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway, with a focus on severe eye …
Catheter Precision Announces September 10th, 2025 Record Date for October 10th, 2025 Special Meeting of Stockholders
FORT MILL, S.C., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced that September …
NBME celebrates 110th anniversary of advancing assessment in medical education
PHILADELPHIA, Sept. 04, 2025 (GLOBE NEWSWIRE) -- This year, NBME celebrates 110 years of creating high-quality assessments for medical learners. As a not-for-profit organization, NBME aims to advance assessment of health care professionals to achieve …
Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference
CHASKA, Minn., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at the 24th Annual …
TISSIUM Advances Clinical Pipeline in Hernia Repair Following First FDA Authorization
Paris, France, Cambridge, USA, September 4 2025 - TISSIUM, a MedTech company pioneering biomorphic programmable polymers for tissue reconstruction, today announced further progress in its clinical pipeline of atraumatic solutions following the recent U.S. …
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
CONSHOHOCKEN, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it …
Regeneron Announces Updated Presentation Time for Upcoming Investor Conference
TARRYTOWN, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that it will now present at the Morgan Stanley 23rd Annual Global Healthcare Conference at 7:00 a.m. ET on Monday, September 8, 2025. The …
STRATA Skin Sciences Announces Closing of $2.42 Million Registered Direct Offering
HORSHAM, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (Nasdaq: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of …
Silent Killer: HTLV 2026 Conference Launches Global Campaign to Fight HIV’s “Cousin” Virus Infecting Millions
Philadelphia, PA , Sept. 04, 2025 (GLOBE NEWSWIRE) -- HTLV 2026, the international conference dedicated to advance discovery research on Human T-cell Leukemia Virus Type 1 (HTLV-1), today announced the launch of a global awareness campaign to combat the …
Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension
Another addition to Amneal’s growing complex injectables portfolio reflects leadership in advanced development and manufacturing of complex pharmaceuticals BRIDGEWATER, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the …
Mineralys Therapeutics Announces Closing of Upsized $287.5 Million Underwritten Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
RADNOR, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), …